Clinical Roundup Older patients left behind in progress against lung cancer, Yale study shows February 03, 2023Vol.49 No.05
Clinical Roundup SWOG S1416 study results show PARP inhibitor benefit in “BRCA-like” breast cancer February 03, 2023Vol.49 No.05
Clinical Roundup Yale-led trial shows significant disease-free survival in NSCLC February 03, 2023Vol.49 No.05
Clinical Roundup KEYNOTE-991 trial evaluating Keytruda + Xtandi + androgen deprivation therapy in hormone-sensitive prostate cancer is stopped for futility February 03, 2023Vol.49 No.05
Clinical Roundup Momelotinib provides significant symptom and anemia improvements for myelofibrosis February 03, 2023Vol.49 No.05
Clinical Roundup Immunotherapy + targeted therapy for CRC shows positive phase II results February 03, 2023Vol.49 No.05
Clinical Roundup UH Seidman study demonstrates importance of SDOH when evaluating the association of race and cancer outcomes February 03, 2023Vol.49 No.05
Clinical Roundup Rezlidhia shows positive results for mIDH1 AML in phase I/II study February 03, 2023Vol.49 No.05
Clinical Roundup Phase II study shows positive results for new treatment for a form of intrahepatic cholangiocarcinoma February 03, 2023Vol.49 No.05
Clinical Roundup UH Seidman discovers newly-approved NSCLC could also treat rare advanced pancreatic cancer February 03, 2023Vol.49 No.05
